Dr. Plott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
12469 Timberland Blvd
Ste 501
Fort Worth, TX 76244Phone+1 817-431-6555Fax+1 817-431-7979- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterResidency, Dermatology, 1992 - 1993
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Dermatology, 1989 - 1992
- University of Texas Medical Branch School of MedicineClass of 1989
- Southern Nazarene UniversityB.S., Biology/Chemistry and History, 1980 - 1984
- Lubbock Christian SchoolE.M.T., 1979 - 1980
Certifications & Licensure
- AZ State Medical License 2003 - Present
- TX State Medical License 1990 - 2024
- CA State Medical License 2009 - 2024
- NJ State Medical License 1994 - 2003
- PA State Medical License 1995 - 1996
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Outstanding Alumni Southern Nazarene University, 1997
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsAn open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis.Joel Schlessinger, Bruce Miller, Richard D. Gilbert, R. Todd Plott> ;Archives of Dermatology. 2006 Dec 1
- Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique.Plott, R. T., Wagner, R. F., Tyring, S. K.> ;Arch Dermatol. 1990 Nov
- 6 citationsModern treatment approaches to vitiligo.R. T. Plott, Richard F. Wagner> ;Cutis. 1990 May 1
- Join now to see all
Journal Articles
- Clinical Safety and Efficacy Studies of a Novel Formulation Combining 12% Clindamycin Phosphate and 0025% Tretinoin fo the Treatment of Acne VulgarisSchlessinger J, Menter A, Gold M, Leonardi C, Eichenfield L, Leyden J, Wortzman M, J Drugs Dermatol, 1/1/2007
- Safety and Efficacyof a New Extended-release Formulation of MinocyclineFleischer AB, Dinehart S, Stough D, Cutis, 1/1/2006
- A Multicenter, Open-label Study to Assess the Safety and Efficacy of Ciclopirox Topical Suspension 077% in the Treatment of Diaper Dermatitis due to Candida albicansGallup E, Plott RT, J Drugs Derm, 1/1/2005
- Join now to see all
Lectures
- Conducting Drug Studies: What You Should Know1/1/2002
- Posaconazole: A Novel Broad-Spectrum TriazoleMadrid, Spain - 1/1/2000
- Melanoma: Diagnosis & Therapeutic Options1/1/2000
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: